Digital Content 
NEWS #PharmaBuzz
11 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-receives-first-country-approval-in-europe-to-begin-recruiting-for-the-miracle-phase-3-rr-acute-myeloid-leukemia-aml-pivotal-trial-302372939.html
12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-receives-institutional-review-board-approval-for-miracle-phase-3-pivotal-trial-of-annamycin-in-combination-with-cytarabine-for-the-treatment-of-rr-acute-myeloid-leukemia-aml-302301750.html
14 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-announces-additional-positive-preliminary-interim-data-from-aml-clinical-trial-302172685.html
25 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-announces-positive-interim-data-in-annamycin-mb-106-phase-1b2-aml-trial-302097561.html
30 Dec 2023
// INDIAN PHARMA POST
https://www.indianpharmapost.com/news/venus-remedies-secures-marketing-approval-from-israel-colombia-for-two-oncology-drugs-15078
02 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-doses-first-subjects-in-phase-2-portion-of-clinical-trial-evaluating-annamycin-in-combination-with-cytarabine-ara-c-for-the-treatment-of-acute-myeloid-leukemia-aml-301943789.html
Share 